Abstract
Metabolism is fundamental to cell survival, growth, and behavior. Tumor cells have an enhanced demand for nutrients which provide biosynthetic building blocks and cellular energy to sustain their proliferative status. Altered metabolism is a hallmark of cancer. The term metabolic reprogramming has been coined to describe the whole range of metabolic abnormalities accompanying tumorigenesis and metastasis. Increased glutamine uptake and glutaminolysis are key metabolic traits that have been consistently found on a wide range of human and experimental cancers. Glutaminase proteins control the first step in the glutaminolytic process: the conversion of glutamine to glutamate and ammonium ions. Glutaminase expression has been correlated with malignancy and growth rate on a great variety of tumors. Recent works are now starting to uncover the differential expression of glutaminase isoenzymes and their regulation by oncogenes and tumor suppressor genes. In parallel, glutaminase isoforms are attracting great interest as novel cancer chemotherapeutic targets. The focus of this chapter will highlight the role of glutamine addiction in tumor biology with particular emphasis on the interaction between the host and the tumor.
Dedicatory: This work is dedicated to Professor Dr. Ignacio Núñez de Castro on occasion of his 77th birthday. His early vision on the relevance of glutamine and glutaminases in cancer growth and proliferation, along with his seminal metabolic works in experimental tumors, paved the way for fertile research lines now being developed for many of us who had the privilege of being inspired by his example and master guidance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- α-KG:
-
2-Oxoglutarate
- APC/C:
-
Anaphase-promoting complex/cyclosome
- CE-MS:
-
Capillary electrophoresis coupled to mass spectrometry
- EAA:
-
Essential amino acids
- EATC:
-
Ehrlich ascites tumor cells
- EGF:
-
Epidermal growth factor
- FMNL3:
-
Formin-like protein 3
- GA:
-
Glutaminase
- GDH:
-
Glutamate dehydrogenase
- GFAT:
-
Glutamine:fructose-6-P amidotransferase
- GIP:
-
Glutaminase-interacting protein
- GlcN-6-P:
-
Glucosamine-6-phosphate
- GS:
-
Glutamine synthetase
- GSH:
-
Reduced glutathione
- GSSG:
-
Oxidized glutathione
- HBP/HEX:
-
Hexosamine biosynthetic pathway
- HDAC:
-
Histone deacetylase
- H3K4me3:
-
Histone H3 trimethyl Lys4
- HMGA2:
-
High-mobility-group AT-hook protein 2
- IDH1:
-
Isocitrate dehydrogenase 1
- IMM:
-
Inner mitochondrial membrane
- LDH:
-
Lactate dehydrogenase
- MCA:
-
Methylcholanthrene induced
- mTORC1:
-
Mammalian target of rapamycin complex 1
- MUC-1:
-
Mucin 1
- NEDD-4:
-
Neural precursor cell-expressed developmentally downregulated gene 4
- NF-κB:
-
Nuclear factor-kappa B
- NMR:
-
Nuclear magnetic resonance
- O-GlcNAc:
-
O-Linked N-acetyl-glucosamine
- OXPHOS:
-
Oxidative phosphorylation
- PFKFB3:
-
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase, isoform 3
- PK:
-
Pyruvate kinase
- PPP:
-
Pentose phosphate pathway
- ROS:
-
Reactive oxygen species
- SCF:
-
Skp1/cullin/F-box
- SMP:
-
Submitochondrial particles
- TCA:
-
Tricarboxylic acid cycle
- TGF-β:
-
Transforming growth factor beta
- UDP-GlcNAc:
-
UDP-N-acetylglucosamine
- USP-15:
-
Ubiquitin carboxyl-terminal hydrolase 15
References
Abou-Khalil WH, Yunis AA, Abou-Khalil S (1983) Prominent glutamine oxidation activity in the mitochondria of hematopoietic tumors. Cancer Res 43:1990–1993
Aledo JC (2004) Glutamine breakdown in rapidly dividing cells: waste or investment? BioEssays 26:778–785
Aledo JC, Segura JA, Medina MA et al (1994) Phosphate-activated glutaminase expression during tumor development. FEBS Lett 341:39–42
Aledo JC, Segura JA, Barbero LG et al (1998) Early differential expression of two glutaminase mRNAs in mouse spleen after tumor implantation. Cancer Lett 133:95–99
Aledo JC, de Pedro E, Gómez-Fabre PM et al (2000a) Changes in mRNAs for enzymes of glutamine metabolism in the tumor-bearing mouse. Anticancer Res 20:1463–1466
Aledo JC, Gómez-Fabre PM, Olalla L et al (2000b) Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm Genome 11:1107–1110
Almeida A, Bolaños JP, Moncada S (2010) E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci USA 107:738–741
Ardawi MS, Newsholme EA (1983) Glutamine metabolism in lymphocytes of the rat. Biochem J 212:835–842
Ardawi MS, Newsholme EA (1985) Fuel utilization in colonocytes of the rat. Biochem J 231:713–719
Argilés JM, Azcón-Bieto J (1988) The metabolic environment of cancer. Mol Cell Biochem 81:3–17
Asiago VM, Alvarado LZ, Shanaiah N et al (2010) Early detection of recurrent breast cancer using metabolite profiling. Cancer Res 70:8309–8318
Battaglia FC (2000) Glutamine and glutamate exchange between the fetal liver and the placenta. J Nutr 130:974S–977S
Bode BP, Fuchs BC, Hurley BP et al (2002) Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am J Physiol Gastrointest Liver Physiol 283:G1062–G1073
Brand K, Williams JF, Weidemann MJ (1984) Glucose and glutamine metabolism in rat thymocytes. Biochem J 221:471–475
Bungard CI, McGivan JD (2004) Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter. Biochem J 382:27–32
Campos JA, Aledo JC, del Castillo-Olivares A et al (1998) Involvement of essential cysteine and histidine residues in the activity of isolated glutaminase from tumour cells. Biochim Biophys Acta 1429:275–283
Campos-Sandoval JA, López de la Oliva AR, Lobo C et al (2007) Expression of functional human glutaminase in baculovirus system: affinity purification, kinetic and molecular characterization. Int J Biochem Cell Biol 39:765–773
Carrascosa JM, Martinez P, Núñez de Castro I (1984) Nitrogen movement between host and tumor in mice inoculated with Ehrlich ascitic tumor cells. Cancer Res 44:3831–3835
Castell LM, Bevan SJ, Calder P et al (1994) The role of glutamine in the immune system and in intestinal function in catabolic states. Amino Acids 7:231–243
Chen MK, Espat NJ, Bland KI (1993) Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney. Ann Surg 217:655–666
Cheng T, Sudderth J, Yang C et al (2011) Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci USA 108:8674–8679
Christofk HR, Vander Heiden MG, Harris MH et al (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452:230–233
Coles NW, Johnstone RM (1962) Glutamine metabolism in Ehrlich ascites-carcinoma cells. Biochem J 83:284–291
Collins CL, Wasa M, Souba WW et al (1998) Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines. J Cell Physiol 176:166–178
Colombo SL, Palacios-Callender M, Frakich N et al (2010) Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes. Proc Natl Acad Sci USA 107:18868–18873
Colombo SL, Palacios-Callender M, Frakich N et al (2011) Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized Hela cells. Proc Natl Acad Sci USA 108:21069–21074
Cornu M, Albert V, Hall MN (2013) mTOR in aging, metabolism, and cancer. Curr Opin Genet Dev 23:53–62
Csibi A, Fendt SM, Li C et al (2013) The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 153:840–854
Dang CV (2010) Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 70:859–862
Daye D, Wellen KE (2012) Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin Cell Dev Biol 23:362–369
De Groot J, Sontheimer H (2011) Glutamate and the biology of gliomas. Glia 59:1181–1189
de la Rosa V, Campos-Sandoval JA, Martín-Rufián M (2009) A novel glutaminase isoform in mammalian tissues. Neurochem Int 55:76–84
DeBerardinis RJ, Cheng T (2010) Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29:313–24
DeBerardinis RJ, Mancuso A, Daikhin E et al (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104:19345–19350
Donadio AC, Lobo C, Tosina M et al (2008) Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells. J Cell Biochem 103:800–811
Dudrick PS, Inoue Y, Espat NJ et al (1993) Na+-dependent glutamine transport in the liver of tumour-bearing rats. Surg Oncol 2:205–215
Duran RV, Oppliger W, Robitaille AM et al (2012) Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 47:349–358
Elgadi KM, Meguid RA, Qian M et al (1999) Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1:51–62
Elstrom RL, Bauer DE, Buzzai M et al (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892–3899
Fischer JE, Chance WT (1990) Total parenteral nutrition, glutamine, and tumor growth. JPEN J Parenter Enteral Nutr 14:86S–89S
Fischer CP, Bode BP, Souba WW (1998) Adaptive alterations in cellular metabolism with malignant transformation. Ann Surg 227:627–634
Gao P, Tchernyshyov I, Chang TC et al (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762–765
Giacobbe A, Bongiorno-Borbone L, Bernassola F et al. (2013) p63 regulates glutaminase 2 expression. Cell Cycle 12:1395–1405.
Goossens V, Grooten J, Fiers W (1996) The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J Biol Chem 271:192–196
Ham RG, McKeehan WL (1979) Media and growth requirements. Methods Enzymol 58:44–93
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hensley CT, Wasti AT, DeBerardinis RJ (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123:3678–3684
Hu W, Zhang C, Wu R et al (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci USA 107:7455–7460
Indiveri C, Abruzzo G, Stipani I et al (1998) Identification and purification of the reconstitutively active glutamine carrier from rat kidney mitochondria. Biochem J 333:285–290
Kawamura I, Moldawer LL, Keenan RA et al (1982) Altered amino acid kinetics in rats with progressive tumor growth. Cancer Res 42:824–829
Knox WE, Horowitz ML, Friedell GH (1969) The proportionality of glutaminase content to growth rate and morphology of rat neoplasms. Cancer Res 29:669–680
Knox WE, Linder M, Friedell GH (1970) A series of transplantable rat mammary tumors with graded differentiation, growth rate, and glutaminase content. Cancer Res 30:283–287
Kovacevic Z, McGivan JD (1983) Mitochondrial metabolism of glutamine and glutamate and its physiological significance. Physiol Rev 63:547–605
Kovacevic Z, Morris HP (1972) The role of glutamine in the oxidative metabolism of malignant cells. Cancer Res 32:326–333
Kowalchuk JM, Curi R, Newsholme EA (1988) Glutamine metabolism in isolated incubated adipocytes of the rat. Biochem J 249:705–708
Krebs H (1980) Glutamine metabolism in animal body. In: Mora J, Palacios R (eds) Glutamine: metabolism, enzymology and regulation. Academic, New York, pp 319–329
Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13:472–482
Kvamme E, Svenneby G (1960) Effect of anaerobiosis and addition of keto acids on glutamine utilization by Ehrlich ascites-tumor cells. Biochim Biophys Acta 42:187–188
Kvamme E, Svenneby G (1961) The effect of glucose on glutamine utilization by Ehrlich ascites tumor cells. Cancer Res 21:92–98
La Noue KF, Schoolwerth AC (1979) Metabolite transport in mitochondria. Annu Rev Biochem 48:871–922
Lacey JM, Wilmore DW (1990) Is glutamine a conditionally essential amino acid? Nutr Rev 48:297–309
Linder-Horowitz M, Knox WE, Morris HP (1969) Glutaminase activities and growth rates of rat hepatomas. Cancer Res 29:1195–1199
Liu W, Le A, Hancock C et al (2012) Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci USA 109:8983–8988
Lobo C, Ruiz-Bellido MA, Aledo JC et al (2000) Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J 348:257–261
Lora J, Alonso FJ, Segura JA et al (2004) Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur J Biochem 271:4298–4306
Low SY, Salter M, Knowles RG et al (1993) A quantitative analysis of the control of glutamine catabolism in rat liver cells. Use of selective inhibitors. Biochem J 295:617–624
Lundholm K, Byland AC, Holm J et al (1976) Skeletal muscle metabolism in patients with malignant tumor. Eur J Cancer 12:465–473
Ma Z, Vosseller K (2013) O-GlcNAc in cancer biology. Amino Acids 45:719–733
Marin-Valencia I, Yang C, Mashimo T et al (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 15:827–837
Márquez J, Núñez de Castro I (1991) Mouse liver free amino acids during the development of Ehrlich ascites tumour. Cancer Lett 58:221–224
Márquez J, Sánchez-Jiménez F, Medina MA et al (1989) Nitrogen metabolism in tumor bearing mice. Arch Biochem Biophys 268:667–675
Márquez J, López de la Oliva AR, Matés JM et al (2006) Glutaminase: a multifaceted protein not only involved in generating glutamate. Neurochem Int 48:465–471
Martín-Rufián M, Segura JA, Lobo C et al (2006) Identification of genes down-regulated in tumor cells expressing antisense glutaminase mRNA by Differential Display. Cancer Biol Ther 5:54–58
Martín-Rufián M, Tosina M, Campos-Sandoval JA et al (2012) Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism. PLoS One 7:e38380
Martín-Rufián M, Nascimento-Gomes R, Higuero A et al (2014) Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells. J Mol Med (Berl) 92(3):277–290, PMID: 24276018
Matés JM, Pérez-Gómez C, Núñez de Castro I et al (2002) Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int J Biochem Cell Biol 34:439–58
Matés JM, Segura JA, Campos-Sandoval JA (2009) Glutamine homeostasis and mitochondrial dynamics. Int J Biochem Cell Biol 41:2051–2061
Matsuno T, Hirai H (1989) Glutamine synthetase and glutaminase activities in various hepatoma cells. Biochem Int 19:219–225
Matsuno T, Satoh T (1986) Glutamine metabolism in the avian host bearing transplantable hepatomatous growth induced by MC-29 virus. Int J Biochem 18:187–189
Matsuno T, Satoh T, Suzuki H (1986) Prominent glutamine oxidation activity in mitochondria of avian transplantable hepatoma induced by MC-29 virus. J Cell Physiol 128:397–401
Mazurek S, Boschek CB, Hugo F et al (2005) Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15:300–308
McGivan JD, Bungard CI (2007) The transport of glutamine into mammalian cells. Front Biosci 12:874–882
McKeehan WL (1982) Glycolysis, glutaminolysis and cell proliferation. Cell Biol Int Rep 6:635–650
McKeehan WL (1986) Glutaminolysis in animal cells. In: Morgan MJ (ed) Carbohydrate metabolism in cultured cells. Plenum Press, New York, pp 111–150
Medina MA, Núñez de Castro I (1990) Glutaminolysis and glycolysis interactions in proliferant cells. Int J Biochem 22:681–683
Medina MA, Márquez J, Núñez de Castro I (1992) Interchange of amino acids between tumor and host. Biochem Med Metab Biol 48:1–7
Mider GB (1951) Some aspects of nitrogen and energy metabolism in cancerous subjects: a review. Cancer Res 11:821–829.
Molina M, Segura JA, Aledo JC et al (1995) Glutamine transport by vesicles isolated from tumour-cell mitochondrial inner membrane. Biochem J 308:629–633
Moncada S, Higgs EA, Colombo SL (2012) Fulfilling the metabolic requirements for cell proliferation. Biochem J 446:1–7
Moreadith RW, Lehninger AL (1984) The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. J Biol Chem 259:6215–6221
Müller F (1889) Stoffwechseluntersuchungen bei Krebskranken. Ztschr f klin Med 16:496–549.
Neermann J, Wagner R (1996) Comparative analysis of glucose and glutamine metabolism in transformed mammalian cell lines, insect and primary liver cells. J Cell Physiol 166:152–169
Nicklin P, Bergman P, Zhang B et al (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136:521–534
Olalla L, Gutiérrez A, Campos JA et al. (2002) Nuclear localization of L-glutaminase in mammalian brain. J Biol Chem 277:38939–38944.
Pérez-Gómez C, Campos-Sandoval JA, Alonso FJ et al (2005) Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem J 386:535–542
Pine MJ, Kim U, Ip C (1982) Free amino acid pools of rodent mammary tumors. J Natl Cancer Inst 69:729–735
Porter LD, Ibrahim H, Taylor L et al (2002) Complexity and species variation of the kidney-type glutaminase gene. Physiol Genomics 9:157–166
Quesada AR, Medina MA, Márquez J et al (1988) Contribution by host tissues to circulating glutamine in mice inoculated with Ehrlich ascites tumor cells. Cancer Res 48:1551–1553
Rathore MG, Saumet A, Rossi J-F et al (2012) The NF-Κb member p65 controls glutamine metabolism through miR-23a. Int J Biochem Cell Biol 44:1448–1456
Reitzer LJ, Wice BM, Kennell D (1979) Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem 254:2669–76
Rivera S, Azcón-Bieto J, López-Soriano FJ et al (1988) Amino acid metabolism in tumour-bearing mice. Biochem J 249:443–9
Sastrasinh S, Sastrasinh M (1989) Glutamine transport in submitochondrial particles. Am J Physiol 257:F1050–F1058
Sauer LA, Dauchy RT (1983) Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats. Cancer Res 43:3497–3503
Sauer LA, Stayman JW 3rd, Dauchy RT (1982) Amino acid, glucose, and lactic acid utilization in vivo by rat tumors. Cancer Res 42:4090–4097
Sebolt JS, Weber G (1984) Negative correlation of L-glutamine concentration with proliferation rate in rat hepatomas. Life Sci 34:301–306
Segura JA, Medina MA, Alonso FJ et al (1989) Glycolysis and glutaminolysis in perifused Ehrlich ascites tumour cells. Cell Biochem Funct 7:7–10
Segura JA, Barbero LG, Márquez J (1997) Early tumor effect on splenic Th lymphocytes in mice. FEBS Lett 414:1–6
Segura JA, Ruiz-Bellido MA, Arenas M et al (2001) Ehrlich ascites tumor cells expressing anti-sense glutaminase mRNA lose their capacity to evade the mouse immune system. Int J Cancer 91:379–384
Shapot VS (1979) On the multiform relationships between the tumor and the host. Adv Cancer Res 39:89–150
Shapot VS (1980) Manifestations and mechanisms of systemic effect of tumours on the host. In: Biochemical aspects of tumor growth. MIR Publishers, Moscow, pp 124–175
Simpson NE, Tryndyak VP, Pogribna M et al (2012) Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype. Epigenetics 7:1413–1420
Souba WW (1993) Glutamine and cancer. Ann Surg 218:715–728
Souba WW, Strebel FR, Bull JM et al (1988) Interorgan glutamine metabolism in the tumor-bearing rat. J Surg Res 44:720–726
Spittler A, Oehler R, Goetzinger P et al (1997) Low glutamine concentrations induce phenotypical and functional differentiation of U937 myelomonocytic cells. J Nutr 127:2151–2157
Sri-Pathmanathan RM, Braddock P, Brindle KM (1990) 31P-NMR studies of glucose and glutamine metabolism in cultured mammalian cells. Biochim Biophys Acta 1051:131–137
Suzuki S, Tanaka T, Poyurovsky MV et al (2010) Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA 107:7461–7466
Szeliga M, Sidoryk M, Matyja E et al (2005) Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neurosci Lett 374:171–173
Szeliga M, Obara-Michlewska M, Matyja E et al (2009) Transfection with liver-type glutaminase (LGA) cDNA alters gene expression and reduces viability, migration and proliferation of T98G glioma cells. Glia 57:1014–1023
Szeliga M, Bogacińska-Karaś M, Różycka A et al (2013) Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells. Tumour Biol 35(3):1855–1862, PMID: 24096582
Tennant DA, Durán RV, Boulahbel H et al (2009) Metabolic transformation in cancer. Carcinogenesis 30:1269–1280
Thangavelu K, Pan CQ, Karlberg T et al (2012) Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolism. Proc Natl Acad Sci USA 109:7705–7710
Turner A, McGivan JD (2003) Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J 370:403–408
Turowski GA, Rashid Z, Hong F et al (1994) Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines. Cancer Res 54:5974–5980
Unterluggauer H, Mazurek S, Lener B et al. (2008) Premature senescence of human endothelial cells induced by inhibition of glutaminase. Biogerontology 9:247–259
van den Heuvel AP, Jing J, Wooster RF et al (2012) Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biol Ther 13:1185–1194
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Voet D, Voet JG (1995) Biochemistry, 2nd edn. Wiley, New York, pp 464–470
Vousden KH (2010) Alternative fuel- another role for p53 in the regulation of metabolism. Proc Natl Acad Sci USA 107:7717–7718
Wang J-B, Erickson JW, Fuji R et al (2010) Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18:207–219
Weber G (1977) Enzymology of cancer cells (second of two parts). N Engl J Med 296:541–551
Wellen KE, Hatzivassilou G, Sachdeva UM et al (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324:1076–1080
Wellen KE, Lu C, Mancuso A et al (2010) The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev 24:2784–2799
Wilson KF, Erickson JW, Antonyak MA et al (2013) Rho GTPases and their role in cancer metabolism. Trends Mol Med 19:74–82
Wise DR, DeBerardinis RJ, Mancuso A et al (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105:18782–18787
Xiang L, Xie G, Liu C et al (2013) Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation. Biochim Biophys Acta 1833:2996–3005
Yuneva M (2008) Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle 7:2083–9
Yuneva M, Zamboni N, Oefner P et al (2007) Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178:93–105
Yuneva M, Fan TWM, Allen TD (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 15:157–170
Zachara NE, Hart GW (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673:13–28
Zielke HR, Sumbilla CM, Sevdalian DA et al (1980) Lactate: a major product of glutamine metabolism by human diploid fibroblasts. J Cell Physiol 104:433–441
Acknowledgements
We are grateful to everybody in the Canceromics group at University of Málaga for creating most of the own work described in this chapter. This work was supported by grants SAF2010-17573 from the Ministry of Science and Innovation of Spain, Excellence Grant CVI-6656 from the regional Andalusian government (Junta de Andalusia), and Grant RD06/1012 of the RTA RETICS (Red Temática de Investigación Cooperativa en Salud) network from the Spanish Health Institute Carlos III. We also wish to thank Prof. G. Lubec for the important support obtained from his Neuroproteomics lab (Vienna) and to Dr. H. Leban for thoughtful discussions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Wien
About this chapter
Cite this chapter
Márquez, J., Matés, J.M., Alonso, F.J., Martín-Rufián, M., Lobo, C., Campos-Sandoval, J.A. (2015). Canceromics Studies Unravel Tumor’s Glutamine Addiction After Metabolic Reprogramming. In: Mazurek, S., Shoshan, M. (eds) Tumor Cell Metabolism. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1824-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1824-5_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1823-8
Online ISBN: 978-3-7091-1824-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)